Machine learning based modeling to predict inhibitors for targets of Alzheimer’s Disease
Mehak Gopal, Nalin Arora · 2026
Read Machine learning based modeling to predict inhibitors for targets of Alzheimer’s Disease by Mehak Gopal, Nalin Arora (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2606-24372.txt.
Description
Gopal and Arora train machine learning models to predict drug candidates against three Alzheimer's disease targets. Alzheimer's is a progressive neurodegenerative disorder projected to affect well over a hundred million people by mid-century. The targets reflect leading theories of the disease: BACE-1 from the amyloid hypothesis, AChE from the cholinergic hypothesis, and GSK-3 beta, tied to insulin signalling disruption.
Models for every target score above the strong discrimination threshold the authors report on the ROC measure. BACE-1 models reach high accuracy but draw on limited chemical diversity, a warning that they may have memorised a narrow family of compounds. AChE models combine similar performance with greater chemical diversity. GSK-3 beta models post comparable discrimination and the highest proportion of viable drug candidates. Gopal and Arora conclude in 2026 that AChE and GSK-3 beta emerge as the most promising targets for machine-learning-guided inhibitor screening.
Catalog record
| CREATOR | Mehak Gopal, Nalin Arora |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 16 KB |
| LICENSE | http://creativecommons.org/licenses/by/4.0/ |
| RIGHTS | CC BY |
| SOURCE | arXiv |
Source: https://arxiv.org/abs/2606.24372